American Medical Technologies (North American) Ltd.
American Medical Technologies (North American) Ltd.: Blood Cell Morphometric Method
American Medical Technologies (North American) Ltd. / Miscellaneous 07.05.2010 14:15 Dissemination of a Corporate News, transmitted by DGAP - a company of EquityStory AG. The issuer / publisher is solely responsible for the content of this announcement. --------------------------------------------------------------------------- MANALAPAN, NJ, USA | May 5, 2010 - American Medical Technologies announced today that implementation of proprietary Blood Cell Morphometric Method (BCMM) technology has included 2 phases in parallel: 1. Phase 1 included, prototype software development based on existing Ludl XY stages and focus motor, Ludl XYZ control box with rs-232 communication with main computer, Nikon Eclipse 50i motorized microscope and QICAM digital camera with resolution 1392 X 1040 pix. Original system software for image processing was Media Cybernetics Image-Pro with IP language. There were 12 versions of software and 13th version of a System has been doing the following: a) Automatically scans a blood smear (in snake or snake with return mode accordingly method recommendations and specs) and found cells and their coordinates with predictable or autofocus on each cell, then b) Measures each cell nuclei and membrane parameters to create necessary statistics to diagnose cancer; c) Extracts small mosaic images of found cells; d) Places collected data and images into proper directories to repeat measurements; e) Provides macros to measure cells in manual mode; f) Implements overlaid graphics to visualize the inspection results (outline); g) Implements operator images sorting and automated data sorting related to accepted images; h) Selects range of color and morphological cells parameters to accommodate variations in color and blood smears quality.In order to enhance some limitations of Image-Pro Software and control box, American Medical Technologies, has started Phase 2 - a process of prototype transformation into production unit: We established contacts with American branch of Objective Imaging, Ltd (Cambridge, United Kingdom): in parallel with developing prototype system, we have started working together to create production unit. Major steps of transformation into production unit are the following: a) Implementation of the next generation Objective Imaging Universal PCI board for control of motorized stages, focus, and a fourth axis, which has two major parts: motion control and Image control software. According to Objective Imaging, the OASIS-blue controller sets the new standard is high-performance automation control. The ultra-compact design and Universal PCI bus interface ensure maximum compatibility while delivering the highest performance. In addition, we has been implemented Objective Imaging Surveyor-stand-alone software for acquiring and visualizing large-scale mosaic images, hardware solutions for frame-rate mosaic image acquisition and OPAL Image Processing Management Library. Objective Imaging permits to collect 12000 images (area over 150 sq.mm of the blood smear) in 25 min. This is data based on max performance of our Biopoint 2 XY stage with optimized acceleration on the new board. As a result we can get the blood smear electronic image (tile image), which can be re-measured and verified any number of times. b) Testing of algorithms on collected images and measurements verification. We implemented prototype algorithms in IpBasic language. c) The next step is the transition to compiled version of Image-Pro to accelerate calculations and acquisition. We work with Objective Imaging Inc. on integration of our algorithms into OPAL library. Library has all set of functions which will substitute the ones in Media Cybernetics Image-Pro. Objective Imaging gives us the possibility to work with only one company software with single licensing. d) Hardware implementation for production system. e) Started enhancing autofocus algorithms for precise measurements. f) We are planning to use Nikon 55i microscope with LED light and LU Nikon objectives as more stable and reliable for our measurements. For Investor Relations please contact our offices at 1-800-239-5AMT (5268) or by e-mail investor@americanmedtec.com 07.05.2010 Ad hoc announcement, Financial News and Media Release distributed by DGAP. Media archive at www.dgap-medientreff.de and www.dgap.de ---------------------------------------------------------------------------
Aktuelle News
Aktuelle Berichte
Keine Berichte gefunden
Anstehende Events
Keine Events gefunden
Webcasts
Keine Webcasts gefunden